Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01353430 · ClinicalTrials.gov registry record
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
A clinical trial of Frontotemporal Dementia and Myopathy, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT01353430 is a study of Frontotemporal Dementia and Myopathy that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 50 participants, below the 1,195-participant average among 22 other Frontotemporal Dementia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01353430, a study of Frontotemporal Dementia and Myopathy, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are researching families with inherited inclusion body myopathy (IBM) and/or Paget disease of bone (PDB) and/or dementia (FTD) which is also called IBMPFD. IBMPFD is caused by mutations in the VCP gene. Our main goal is to understand how changes in the VCP gene cause the muscle, bone and cognitive problems associated with the disease. The investigators are collecting biological specimen such as blood and urine samples, family and medical histories, questionnaire data of patients with a personal or family history of VCP associated disease. Participants do not need to have all symptoms listed above in order to qualify. A select group of participants may be invited to travel to University of California, Irvine for a two day program of local procedures such as an MRI and bone scan. Samples are coded to maintain confidentiality. Travel is not necessary except for families invited for additional testing.
Conditions Studied
Study Locations (1)
California
- University of California, Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-11-15 |
| Est. Completion | 2030-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01353430
The ClinicalTrials.gov registry entry for NCT01353430 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,195-participant average among 22 other Frontotemporal Dementia trials with a reported enrollment target (96% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Frontotemporal Dementia appearing as the primary indexed condition, and to 0 interventions.
NCT01353430 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01353430 about?
NCT01353430 is a clinical study titled "Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)". The investigators are researching families with inherited inclusion body myopathy (IBM) and/or Paget disease of bone (PDB) and/or dementia (FTD) which is also called IBMPFD. IBMPFD is caused by mutations in the VCP gene. Our main goal is to understand how changes in the VCP gene cause the muscle, bo...
What is the current status of trial NCT01353430?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2007-11-15. Estimated completion is 2030-12.
What conditions does trial NCT01353430 study?
This clinical trial studies the following conditions: Frontotemporal Dementia, Myopathy, Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia, Paget Disease of Bone.
Who is sponsoring clinical trial NCT01353430?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01353430 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Frontotemporal Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
RECRUITING
-
Longitudinal Cognitive Assessment by BoCA
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
RECRUITING · Phase 1
-
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
RECRUITING · NA
-
Retinal Imaging in Neurodegenerative Disease
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.